India calls for IP waiver to combat COVID-19
02-03-2021
LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission
01-02-2021
Indian drugmaker joins race to find COVID-19 vaccine
17-02-2020
Anton Balazh / Shutterstock.com
India has granted emergency approval to COVID-19 vaccines developed by AstraZeneca and Oxford University and one from the state-run institute Bharat Biotech, ahead of a huge immunisation drive that is planned to begin this week.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
India, COVID-19, AstraZeneca, Oxford University, Bharat Biotech, Johns Hopkins University
